Literature DB >> 11788976

Commentary on Jack Dowie, "Decision validity should determine whether a generic or condition-specific HRQOL measure is used in health care decisions".

David Feeny1.   

Abstract

Mesh:

Year:  2002        PMID: 11788976     DOI: 10.1002/hec.670

Source DB:  PubMed          Journal:  Health Econ        ISSN: 1057-9230            Impact factor:   3.046


× No keyword cloud information.
  6 in total

1.  Utility estimation in chronic obstructive pulmonary disease: a preference for change?

Authors:  Jennifer Petrillo; Floortje van Nooten; Paul Jones; Maureen Rutten-van Mölken
Journal:  Pharmacoeconomics       Date:  2011-11       Impact factor: 4.981

2.  The role of perinatal problems in risk of co-morbid psychiatric and medical disorders in adulthood.

Authors:  Yoko Nomura; Jeanne Brooks-Gunn; Charles Davey; Jacob Ham; William P Fifer
Journal:  Psychol Med       Date:  2007-05-02       Impact factor: 7.723

3.  Conjoined effects of low birth weight and childhood abuse on adaptation and well-being in adolescence and adulthood.

Authors:  Yoko Nomura; Claude M Chemtob
Journal:  Arch Pediatr Adolesc Med       Date:  2007-02

4.  Mapping of the DLQI scores to EQ-5D utility values using ordinal logistic regression.

Authors:  Faraz Mahmood Ali; Richard Kay; Andrew Y Finlay; Vincent Piguet; Joerg Kupfer; Florence Dalgard; M Sam Salek
Journal:  Qual Life Res       Date:  2017-06-10       Impact factor: 4.147

5.  Economic evaluation of multidisciplinary rehabilitation treatment versus cognitive behavioural therapy for patients with chronic fatigue syndrome: A randomized controlled trial.

Authors:  Desirée Vos-Vromans; Silvia Evers; Ivan Huijnen; Albère Köke; Minou Hitters; Nieke Rijnders; Menno Pont; André Knottnerus; Rob Smeets
Journal:  PLoS One       Date:  2017-06-02       Impact factor: 3.240

6.  Estimating a preference-based index from the Clinical Outcomes in Routine Evaluation-Outcome Measure (CORE-OM): valuation of CORE-6D.

Authors:  Ifigeneia Mavranezouli; John E Brazier; Donna Rowen; Michael Barkham
Journal:  Med Decis Making       Date:  2012-11-25       Impact factor: 2.583

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.